Growth Metrics

Bio-Rad Laboratories (BIO) Cash from Investing Activities (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Cash from Investing Activities for 17 consecutive years, with -$34.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 12.13% to -$34.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$189.7 million through Dec 2025, down 18.41% year-over-year, with the annual reading at -$189.7 million for FY2025, 18.41% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$34.2 million at Bio-Rad Laboratories, up from -$43.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $72.2 million in Q4 2023, with the low at -$916.1 million in Q1 2022.
  • Average Cash from Investing Activities over 5 years is -$116.7 million, with a median of -$52.0 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities tumbled 1795.71% in 2022, then soared 223.28% in 2023.
  • Over 5 years, Cash from Investing Activities stood at -$567.4 million in 2021, then skyrocketed by 89.68% to -$58.6 million in 2022, then skyrocketed by 223.28% to $72.2 million in 2023, then crashed by 142.25% to -$30.5 million in 2024, then dropped by 12.13% to -$34.2 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$34.2 million, -$43.0 million, and -$115.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.